3,4-Didehydro-2-ketoglutaric acid

ID: ALA4847806

Max Phase: Preclinical

Molecular Formula: C5H4O5

Molecular Weight: 144.08

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)/C=C/C(=O)C(=O)O

Standard InChI:  InChI=1S/C5H4O5/c6-3(5(9)10)1-2-4(7)8/h1-2H,(H,7,8)(H,9,10)/b2-1+

Standard InChI Key:  KRSRJVGQNCNEFU-OWOJBTEDSA-N

Associated Targets(Human)

TET2 Tchem Methylcytosine dioxygenase TET2 (57 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 144.08Molecular Weight (Monoisotopic): 144.0059AlogP: -0.72#Rotatable Bonds: 3
Polar Surface Area: 91.67Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.30CX Basic pKa: CX LogP: 0.25CX LogD: -6.74
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.40Np Likeness Score: 0.86

References

1. Tiwari AD, Guan Y, Grabowski DR, Maciejewski JP, Jha BK, Phillips JG..  (2021)  SAR insights into TET2 catalytic domain inhibition: Synthesis of 2-Hydroxy-4-Methylene-pentanedicarboxylates.,  39  [PMID:33894507] [10.1016/j.bmc.2021.116141]

Source